Literature DB >> 2241296

Systemic sclerosis: is there a treatment yet?

C M Black1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2241296      PMCID： PMC1004218          DOI： 10.1136/ard.49.9.735

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

Review 1.  Treatment of systemic sclerosis in 1988.

Authors:  F A Wollheim; A Akesson
Journal:  Semin Arthritis Rheum       Date:  1989-02       Impact factor: 5.532

2.  Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration.

Authors:  M B Kahaleh; E C LeRoy
Journal:  Ann Intern Med       Date:  1989-03-15       Impact factor: 25.391

3.  A new promising treatment in systemic sclerosis: 5-fluorouracil.

Authors:  J A Casas; C P Subauste; G S Alarcón
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

4.  Cyclosporin A in systemic sclerosis.

Authors:  H Zachariae; E Zachariae
Journal:  Br J Dermatol       Date:  1987-05       Impact factor: 9.302

5.  Cyclosporine in successful control of rapidly progressive scleroderma.

Authors:  T Appelboom; D Itzkowitch
Journal:  Am J Med       Date:  1987-04       Impact factor: 4.965

6.  Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin.

Authors:  V L Beckett; D L Conn; V Fuster; P J Osmundson; C G Strong; E Y Chao; J H Chesebro; W M O'Fallon
Journal:  Arthritis Rheum       Date:  1984-10

Review 7.  Treatment of systemic sclerosis.

Authors:  T A Medsger
Journal:  Rheum Dis Clin North Am       Date:  1989-08       Impact factor: 2.670

8.  Recombinant interferon-gamma in the treatment of systemic sclerosis.

Authors:  A Kahan; B Amor; C J Menkes; G Strauch
Journal:  Am J Med       Date:  1989-09       Impact factor: 4.965

9.  A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma).

Authors:  J F Fries; C Wasner; J Brown; P Feigenbaum
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

10.  Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study.

Authors:  D E Furst; P J Clements; S Hillis; P A Lachenbruch; B L Miller; M G Sterz; H E Paulus
Journal:  Arthritis Rheum       Date:  1989-05
View more
  4 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo-controlled study.

Authors:  B Sharada; A Kumar; R Kakker; C M Adya; I Pande; S S Uppal; J N Pande; K R Sunderam; A N Malaviya
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

3.  Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity.

Authors:  U Fiocco; M Rosada; L Cozzi; C Ortolani; G De Silvestro; A Ruffatti; E Cozzi; C Gallo; S Todesco
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

4.  Remission of scleroderma during chemotherapy for lymphoma.

Authors:  M Comer; A R Harvey
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.